Acquisition history Target potential clients aware of TangenX’s historical acquisition by Repligen; explore opportunities for cross-sell or post-acquisition integration services, leveraging legacy membrane expertise and established biopharma credibility.

Customization edge Highlight TangenX’s ability to tailor membrane chemistries and molecular weight cutoffs to specific applications as a value proposition for biotech and biopharma firms seeking customized filtration solutions.

Mid-market focus Position as a flexible, specialty membrane supplier serving biopharma, biotech and life sciences sectors with lab-to-process capabilities, appealing to mid-sized companies seeking expert support and scalable membranes.

Strategic partnerships Leverage proximity to Shrewsbury, MA, and established customer collaboration model to pursue partnerships with contract development and manufacturing organizations (CDMOs) and research labs needing customized filtration platforms.

Growth opportunities Given modest revenue and niche specialization, identify expansion opportunities in higher-value membrane products, process-scale filtration, and service offerings to competing firms in the biopharma supply chain seeking reliable filtration partners.